Experts say approved vaccines could raise drop-out concerns for later trials
Experts say approved vaccines could raise drop-out concerns for later trials Experts are concerned approved vaccines could make it harder to find trial participants for later rounds. They say trial drop-out rates could increase, too. and last updated 2020-12-14 19:40:27-05 KANSAS CITY, Mo. â While Pfizers Covid-19 vaccine is approved for public use, doctors say its important to keep in mind multiple vaccines are needed to help end the pandemic as soon as possible. Several trials are still ...
United States Kansas City Brandon Kenig John Ervin Alliance For Multispecialty Research While Pfizer
Source: kshb.com